Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
Hansen, A R, Massard, C, Ott, P A, Haas, N B, Lopez, J S, Ejadi, S, Wallmark, J M, Keam, B, Delord, J-P, Aggarwal, R, Gould, M, Yang, P, Keefe, S M, Piha-Paul, S ALanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy232
Date:
July, 2018
File:
PDF, 660 KB
english, 2018